AptarGroup (NYSE: ATR) reported Q1 EPS of $0.81, $0.06 better than the analyst estimate of $0.75. Revenue for the quarter came in at $601 million versus the consensus estimate of $593.25 million.

• Reported sales grew 3%; growth in Beauty + Home and Pharma offset decline in Food + Beverage
• Excluding the negative impact from changes in foreign currency exchange rates and the positive contribution from an acquisition, core sales also increased 3%
• Reported earnings per share were $0.81, which includes a $0.04 tax benefit not included in previous first quarter guidance, compared to $0.67 in the prior year (+21%); when adjusting for special items and changes in currency exchange rates, comparable earnings per share for the prior year were $0.74 (+9%)
• Earnings per share for both the current and prior year included certain tax benefits amounting to approximately $0.04 in each respective period
• Received the first order for European Medicines Agency (EMA)-approved integrated electronic nasal lockout device (Aptar’s eLockout)
• Acquired 20% minority ownership position in Kali Care, a Silicon Valley-based technology company, which provides digital monitoring systems for ophthalmic medications

For earnings history and earnings-related data on AptarGroup (ATR) click here.